STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs)
Cancer Letters · 2024-04 · 588 · 216700
DOI: 10.1016/j.canlet.2024.216700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-04. Verfasst von Jiale Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong Province, China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Ovarian Neoplasms. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Association for Science and Technology, Shandong Province Department of Science and Technology, Shandong Provincial Education Department.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Chemotherapy resistance in ovarian cancer hampers cure rates, with cancer-associated fibroblasts (CAFs) playing a pivotal role. Despite their known impact on cancer progression and chemotherapy resistance, the specific mechanism by which CAFs regulate the tumor inflammatory environment remains unclear. This study reveals that cisplatin facilitates DNA transfer from ovarian cancer cells to CAFs, activating the CGAS-STING-IFNB1 pathway in CAFs and promoting IFNB1 release. Consequently, this reinforces cancer cell resistance to platinum drugs. High STING expression in the tumor stroma was associated with a poor prognosis, while inhibiting STING expression enhanced ovarian cancer sensitivity. Understanding the relevance of the CGAS-STING pathway in CAFs for platinum resistance suggests targeting STING as a promising combination therapy for ovarian cancer, providing potential avenues for improved treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong Province, China.
- Department of Obstetrics and Gynecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
- Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong Province, China. Electronic address: qiluqingzhang@sdu.edu.cn.
- Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Jinan, 250012, Shandong Province, China. Electronic address: songkun2001226@sdu.edu.cn.
Förderung
- China Association for Science and Technology
- Shandong Province Department of Science and Technology
- Shandong Provincial Education Department
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Liu, J., Liu, C., Ma, Y., Pan, X., Chu, R., Yao, S., Chen, J., Liu, C., Chen, Z., Sheng, C., Zhang, K., Xue, Y., Schiöth, H. B., Kong, B., Zhang, Q., & Song, K. (2024). STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs). Cancer Letters, 588, 216700. https://doi.org/10.1016/j.canlet.2024.216700
Vancouver
Liu J, Liu C, Ma Y, Pan X, Chu R, Yao S, et al. STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs). Cancer Letters. 2024;588:216700. doi:10.1016/j.canlet.2024.216700
BibTeX
@article{Liu2024,
author = {Liu, Jiale and Liu, Chenmian and Ma, Yana and Pan, Xiyu and Chu, Ran and Yao, Shu and Chen, Junyu and Liu, Chang and Chen, Zhongshao and Sheng, Chenchen and Zhang, Kai and Xue, Ying and Schiöth, Helgi B and Kong, Beihua and Zhang, Qing and Song, Kun},
title = {STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs)},
journal = {Cancer Letters},
year = {2024},
volume = {588},
pages = {216700},
doi = {10.1016/j.canlet.2024.216700}
}
EUVIMED